Compile Data Set for Download or QSAR
Report error Found 126 Enz. Inhib. hit(s) with all data for entry = 1938
TargetHistone deacetylase 1(Human)
Regenacy Pharmaceuticals

US Patent
LigandPNGBDBM347485(US9790180, ID 020 | US9790180, ID 019)
Affinity DataIC50: 0.900nMAssay Description:Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
Regenacy Pharmaceuticals

US Patent
LigandPNGBDBM347471(US9790180, ID 005)
Affinity DataIC50: 1.20nMAssay Description:Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
Regenacy Pharmaceuticals

US Patent
LigandPNGBDBM347468(US9790180, ID 004)
Affinity DataIC50: 2nMAssay Description:Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
Regenacy Pharmaceuticals

US Patent
LigandPNGBDBM347482(US9790180, ID 016)
Affinity DataIC50: 3.20nMAssay Description:Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
Regenacy Pharmaceuticals

US Patent
LigandPNGBDBM347481(US9790180, ID 015)
Affinity DataIC50: 3.20nMAssay Description:Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
Regenacy Pharmaceuticals

US Patent
LigandPNGBDBM347485(US9790180, ID 020 | US9790180, ID 019)
Affinity DataIC50: 3.70nMAssay Description:Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
Regenacy Pharmaceuticals

US Patent
LigandPNGBDBM347490(US9790180, ID 023)
Affinity DataIC50: 3.90nMAssay Description:Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
Regenacy Pharmaceuticals

US Patent
LigandPNGBDBM347479(US9790180, ID 013)
Affinity DataIC50: 4nMAssay Description:Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetHistone deacetylase 2(Human)
Regenacy Pharmaceuticals

US Patent
LigandPNGBDBM347485(US9790180, ID 020 | US9790180, ID 019)
Affinity DataIC50: 4.20nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
Regenacy Pharmaceuticals

US Patent
LigandPNGBDBM347472(US9790180, ID 006)
Affinity DataIC50: 4.70nMAssay Description:Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetHistone deacetylase 2(Human)
Regenacy Pharmaceuticals

US Patent
LigandPNGBDBM347471(US9790180, ID 005)
Affinity DataIC50: 4.90nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
Regenacy Pharmaceuticals

US Patent
LigandPNGBDBM347489(US9790180, ID 022)
Affinity DataIC50: 5nMAssay Description:Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
Regenacy Pharmaceuticals

US Patent
LigandPNGBDBM347491(US9790180, ID 024)
Affinity DataIC50: 6nMAssay Description:Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
Regenacy Pharmaceuticals

US Patent
LigandPNGBDBM347455(US9790180, ID 001)
Affinity DataIC50: 6.5nMAssay Description:Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
Regenacy Pharmaceuticals

US Patent
LigandPNGBDBM347459(US9790180, ID 002)
Affinity DataIC50: 7nMAssay Description:Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
Regenacy Pharmaceuticals

US Patent
LigandPNGBDBM347492(US9790180, ID 025)
Affinity DataIC50: 7nMAssay Description:Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
Regenacy Pharmaceuticals

US Patent
LigandPNGBDBM347497(US9790180, ID 030)
Affinity DataIC50: 7.10nMAssay Description:Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
Regenacy Pharmaceuticals

US Patent
LigandPNGBDBM347476(US9790180, ID 010)
Affinity DataIC50: 7.30nMAssay Description:Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
Regenacy Pharmaceuticals

US Patent
LigandPNGBDBM347508(US9790180, ID 040)
Affinity DataIC50: 8nMAssay Description:Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
Regenacy Pharmaceuticals

US Patent
LigandPNGBDBM347477(US9790180, ID 011)
Affinity DataIC50: 8.5nMAssay Description:Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
Regenacy Pharmaceuticals

US Patent
LigandPNGBDBM347474(US9790180, ID 008)
Affinity DataIC50: 9nMAssay Description:Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetHistone deacetylase 2(Human)
Regenacy Pharmaceuticals

US Patent
LigandPNGBDBM347497(US9790180, ID 030)
Affinity DataIC50: 9.40nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
Regenacy Pharmaceuticals

US Patent
LigandPNGBDBM347493(US9790180, ID 026)
Affinity DataIC50: 10nMAssay Description:Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetHistone deacetylase 2(Human)
Regenacy Pharmaceuticals

US Patent
LigandPNGBDBM347481(US9790180, ID 015)
Affinity DataIC50: 12nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
Regenacy Pharmaceuticals

US Patent
LigandPNGBDBM347496(US9790180, ID 029)
Affinity DataIC50: 12nMAssay Description:Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
Regenacy Pharmaceuticals

US Patent
LigandPNGBDBM347484(US9790180, ID 018)
Affinity DataIC50: 12nMAssay Description:Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetHistone deacetylase 2(Human)
Regenacy Pharmaceuticals

US Patent
LigandPNGBDBM347482(US9790180, ID 016)
Affinity DataIC50: 13nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetHistone deacetylase 2(Human)
Regenacy Pharmaceuticals

US Patent
LigandPNGBDBM347479(US9790180, ID 013)
Affinity DataIC50: 14nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
Regenacy Pharmaceuticals

US Patent
LigandPNGBDBM347509(US9790180, ID 041)
Affinity DataIC50: 14nMAssay Description:Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
Regenacy Pharmaceuticals

US Patent
LigandPNGBDBM347488(US9790180, ID 021)
Affinity DataIC50: 15nMAssay Description:Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
Regenacy Pharmaceuticals

US Patent
LigandPNGBDBM347467(US9790180, ID 003)
Affinity DataIC50: 15nMAssay Description:Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
Regenacy Pharmaceuticals

US Patent
LigandPNGBDBM347500(US9790180, ID 032)
Affinity DataIC50: 17nMAssay Description:Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetHistone deacetylase 2(Human)
Regenacy Pharmaceuticals

US Patent
LigandPNGBDBM347485(US9790180, ID 020 | US9790180, ID 019)
Affinity DataIC50: 17nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetHistone deacetylase 2(Human)
Regenacy Pharmaceuticals

US Patent
LigandPNGBDBM347496(US9790180, ID 029)
Affinity DataIC50: 17nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
Regenacy Pharmaceuticals

US Patent
LigandPNGBDBM347507(US9790180, ID 039)
Affinity DataIC50: 17nMAssay Description:Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
Regenacy Pharmaceuticals

US Patent
LigandPNGBDBM347483(US9790180, ID 017)
Affinity DataIC50: 18nMAssay Description:Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetHistone deacetylase 2(Human)
Regenacy Pharmaceuticals

US Patent
LigandPNGBDBM347489(US9790180, ID 022)
Affinity DataIC50: 18nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
Regenacy Pharmaceuticals

US Patent
LigandPNGBDBM347478(US9790180, ID 012)
Affinity DataIC50: 19nMAssay Description:Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetHistone deacetylase 2(Human)
Regenacy Pharmaceuticals

US Patent
LigandPNGBDBM347500(US9790180, ID 032)
Affinity DataIC50: 20nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetHistone deacetylase 2(Human)
Regenacy Pharmaceuticals

US Patent
LigandPNGBDBM347490(US9790180, ID 023)
Affinity DataIC50: 20nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetHistone deacetylase 2(Human)
Regenacy Pharmaceuticals

US Patent
LigandPNGBDBM347468(US9790180, ID 004)
Affinity DataIC50: 21nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetHistone deacetylase 2(Human)
Regenacy Pharmaceuticals

US Patent
LigandPNGBDBM347472(US9790180, ID 006)
Affinity DataIC50: 22nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
Regenacy Pharmaceuticals

US Patent
LigandPNGBDBM347503(US9790180, ID 035)
Affinity DataIC50: 22nMAssay Description:Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetHistone deacetylase 2(Human)
Regenacy Pharmaceuticals

US Patent
LigandPNGBDBM347476(US9790180, ID 010)
Affinity DataIC50: 26nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetHistone deacetylase 2(Human)
Regenacy Pharmaceuticals

US Patent
LigandPNGBDBM347492(US9790180, ID 025)
Affinity DataIC50: 26nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetHistone deacetylase 2(Human)
Regenacy Pharmaceuticals

US Patent
LigandPNGBDBM347509(US9790180, ID 041)
Affinity DataIC50: 26nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetHistone deacetylase 2(Human)
Regenacy Pharmaceuticals

US Patent
LigandPNGBDBM347491(US9790180, ID 024)
Affinity DataIC50: 26nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetHistone deacetylase 2(Human)
Regenacy Pharmaceuticals

US Patent
LigandPNGBDBM347459(US9790180, ID 002)
Affinity DataIC50: 28nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetHistone deacetylase 2(Human)
Regenacy Pharmaceuticals

US Patent
LigandPNGBDBM347477(US9790180, ID 011)
Affinity DataIC50: 32nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
Regenacy Pharmaceuticals

US Patent
LigandPNGBDBM347475(US9790180, ID 009)
Affinity DataIC50: 32nMAssay Description:Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

Displayed 1 to 50 (of 126 total ) | Next | Last >>
Jump to: